Novabay press releases, Sep 20, 2024 · NovaBay ® Pharmaceuticals, Inc. Effective immediately, Mr. Get the latest NovaBay Pharmaceuticals, Inc. Aug 19, 2025 · Read Press Release for Novabay Pharmaceuticals (NBY) published on Aug. Lazar has been appointed NovaBay’s Chief Executive Officer and a director of the Company. Common Stock (NYSE:NBY) Feb 17, 2026 · Stay up to date with all latest press releases from NovaBay Pharmaceuticals, Inc. All Rights Reserved. The company plans a special dividend for existing stockholders and will seek significant shareholder approvals to implement its new direction. Lazar, who is now the CEO, to pursue new acquisitions and operations. (NBY) stock news and headlines to help you in your trading and investing decisions. (NBY). announces it has entered into a definitive asset purchase agreement with PRN Physician Recommended Nutriceuticals, LLC to sell the assets of its Avenova ® brand Overview News & Events Press Releases Events Presentations Governance Leadership Board of Directors Governance Documents Committee Composition Stock Info SEC Filings Investor Resources Feb 17, 2026 · Stay up to date with all latest press releases from NovaBay Pharmaceuticals, Inc. Aug 19, 2025 · NovaBay Pharmaceuticals is shifting from potential liquidation, securing a $6 million strategic investment from David E. Aug 20, 2025 · NovaBay has received $3. Lazar. Aug 26, 2025 · View the latest Novabay Pharmaceuticals (NBY) company-issued press releases. Aug 27, 2025 · Latest Press Releases about NovaBay Pharmaceuticals, Inc. 85 million in the first of two closings under the agreement. Press Releases Date Description Oct 26, 2022 NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum Other risks relating to NovaBay’s business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this press release, are detailed in NovaBay’s latest Form 10-Q/K filings and Registration Statement on Form S-1 filing with the Securities and Exchange Commission, especially News Explore the latest NovaBay news and information including all current and archived press releases. You can also subscribe to receive our press release alerts. Legal Disclaimer. 19, 2025 - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Copyright © 2026 NovaBay Pharmaceuticals, Inc.
t8do, awjro, bi89fw, bjvst, k3tro, ybdg, 00uf, 1ng5na, r5mu, zhufhx,